BiotechTube
Home/NeuroKappa Therapeutics/Yi-yen Chen, PhD
YC

Yi-yen Chen, PhD

Business Development

NeuroKappa Therapeutics

Therapeutic Areas

StrokePain ManagementAddiction TherapyDepression

NeuroKappa Therapeutics Pipeline

DrugIndicationPhase
Salvinorin A Novel AnalogStroke (Neuroprotection)Pre-clinical
Dezocine & Associated ProductsOpioid Addiction Management / PainPre-clinical

Leadership Team at NeuroKappa Therapeutics

PF
Peter Fang, MD, MS
CEO
RL
Renyu Liu, MD, PhD
Founder
JG
John Grothusen, PhD
CSO (Chief Scientific Officer)
GB
Gordon Barr, PhD
DMD (likely Director of Medicinal Chemistry)
LF
Lei Fang, Esq, MD, PhD
Legal Counsel
View full NeuroKappa Therapeutics profile